Search
TAS-106
go.drugbank.com/drugs/DB06656InvestigationalTAS-106 is a new nucleoside antimetabolite. TAS-106 has demonstrated strong antitumor activity without serious toxicity in nude rat models bearing human tumours .
Modotuximab
go.drugbank.com/drugs/DB14827InvestigationalModotuximab is under investigation in clinical trial NCT03549338 (Sym004 Versus Futuximab or Modotuximab in Patients With mCRC).
Erzotabart
go.drugbank.com/drugs/DB19063InvestigationalErzotabart is under investigation in clinical trial NCT04824794 (GEN3014 Safety Trial in Relapsed or Refractory Hematologic Malignancies).
Glucose-6-Phosphate
go.drugbank.com/drugs/DB03581ExperimentalAn ester of glucose with phosphoric acid, made in the course of glucose metabolism by mammalian and other cells.
D-Asparagine
go.drugbank.com/drugs/DB03943ExperimentalIt is biosynthesized from ASPARTIC ACID and AMMONIA by asparagine synthetase. (From Concise Encyclopedia Biochemistry and Molecular Biology, 3rd ed)
Prostaglandin D2
go.drugbank.com/drugs/DB02056ExperimentalIt is released upon activation of mast cells and is also synthesized by alveolar macrophages.
Phenibut
go.drugbank.com/drugs/DB13455ExperimentalCategories: Psychostimulants, Agents Used for ADHD and NootropicsAZD-5991
go.drugbank.com/drugs/DB14792InvestigationalAZD-5991 is under investigation in clinical trial NCT03218683 (Study of AZD5991 in Relapsed or Refractory Haematologic Malignancies.).
Gold
go.drugbank.com/drugs/DB14154InvestigationalMany of its clinical applications, such as ANTIRHEUMATIC AGENTS, are in the form of its salts.
OSI-027
go.drugbank.com/drugs/DB12387InvestigationalOSI-027 has been used in trials studying the treatment of Any Solid Tumor or Lymphoma.